Inventiva S.A.
IVA
$3.07
$0.0451.49%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/4/2025
-
Zacks Investment Research
4/4/2025
-
TipRanks Financial Blog
4/4/2025
-
The Fly
4/3/2025
-
Tickeron - Stocks
4/1/2025
-
TipRanks Financial Blog
4/1/2025
-
Globe Newswire
3/29/2025
-
MarketBeat
3/28/2025
-
GuruFocus
3/28/2025
-
GuruFocus
3/27/2025
-
Seeking Alpha: Transcripts
3/27/2025
-
SeekingAlpha
3/26/2025
-
TipRanks Financial Blog
3/26/2025
-
SeekingAlpha.com: All News
3/26/2025
-
Globe Newswire
3/19/2025
-
MarketBeat
3/16/2025
-
MarketBeat
2/26/2025
-
TipRanks Financial Blog
2/26/2025
-
The Fly
2/22/2025
-
MarketBeat
2/21/2025
-
The Fly
2/20/2025
-
The Fly
1/31/2025
-
MarketBeat
1/29/2025
-
The Fly
1/15/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, October 14, 2024
Period Date
Sunday, June 30, 2024
Next Filing
Beginning of April (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
33 3 80 44 75 00
Address
50 rue de Dijon
Daix, 21121
Daix, 21121
Country
Year Founded
Business Description
Sector
--
Industry
--
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other...
more
